DE69834408D1 - Strukturelles peptid mit antigenischenen eigenschaften, antigenischen verbindungen und verwendungen im nachweis, vorbeugung und behandlung einer vhc-infektion - Google Patents

Strukturelles peptid mit antigenischenen eigenschaften, antigenischen verbindungen und verwendungen im nachweis, vorbeugung und behandlung einer vhc-infektion

Info

Publication number
DE69834408D1
DE69834408D1 DE69834408T DE69834408T DE69834408D1 DE 69834408 D1 DE69834408 D1 DE 69834408D1 DE 69834408 T DE69834408 T DE 69834408T DE 69834408 T DE69834408 T DE 69834408T DE 69834408 D1 DE69834408 D1 DE 69834408D1
Authority
DE
Germany
Prior art keywords
peptide
antigenic
hcv
infection
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834408T
Other languages
English (en)
Other versions
DE69834408T2 (de
Inventor
Michel Jolivet
Francois Penin
Pascal Dalbon
Laurent Ladaviere
Xavier Lacoux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of DE69834408D1 publication Critical patent/DE69834408D1/de
Application granted granted Critical
Publication of DE69834408T2 publication Critical patent/DE69834408T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69834408T 1997-03-05 1998-03-05 Strukturelles Peptid mit antigenischen Eigenschaften, antigenischen Verbindungen und Verwendungen im Nachweis, Vorbeugung und Behandlung einer VHC-Infektion Expired - Lifetime DE69834408T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9702878 1997-03-05
FR9702878A FR2760458B1 (fr) 1997-03-05 1997-03-05 Peptide structural antigenique, composes antigenique et immunogene et utilisations dans la detection, la prevention et le traitement d'une infection par le vhc
PCT/FR1998/000442 WO1998039360A1 (fr) 1997-03-05 1998-03-05 Peptide structural antigenique, composes antigenique et immunogene, et utilisations dans la detection, la prevention et le traitement d'une infection par le vhc

Publications (2)

Publication Number Publication Date
DE69834408D1 true DE69834408D1 (de) 2006-06-08
DE69834408T2 DE69834408T2 (de) 2007-04-19

Family

ID=9504613

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834408T Expired - Lifetime DE69834408T2 (de) 1997-03-05 1998-03-05 Strukturelles Peptid mit antigenischen Eigenschaften, antigenischen Verbindungen und Verwendungen im Nachweis, Vorbeugung und Behandlung einer VHC-Infektion

Country Status (9)

Country Link
US (2) US6576240B1 (de)
EP (1) EP1015481B1 (de)
JP (1) JP2001522352A (de)
AT (1) ATE325130T1 (de)
AU (1) AU6839598A (de)
CA (1) CA2284083A1 (de)
DE (1) DE69834408T2 (de)
FR (1) FR2760458B1 (de)
WO (1) WO1998039360A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
CA2316130A1 (en) * 1999-08-19 2001-02-19 Masanori Fukui Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein
EP1652858A1 (de) * 2004-10-28 2006-05-03 Innogenetics N.V. Peptide zur Induktion von ZTL und/oder HTL Antwort auf Hepatitis C Virus
AU2005250170A1 (en) * 2004-06-01 2005-12-15 Genimmune N.V. Peptides for inducing a CTL and/or HTL response to hepatitis C virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5329698A (en) * 1989-02-06 1994-07-19 Tennessee Gas Pipeline Company Method of assembling a catalytic converter
JP2656995B2 (ja) * 1989-03-17 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
FR2690921B1 (fr) * 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
JPH06327482A (ja) * 1993-05-21 1994-11-29 Imuno Japan:Kk オリゴペプタイド、オリゴヌクレオチドならびにｃ型肝炎ウ イルス関連抗体検出方法
JPH07135981A (ja) * 1993-05-28 1995-05-30 Eisai Co Ltd 非ａ非ｂ型肝炎ウイルス遺伝子に由来するｄｎａ及び構成ポリペプチド
DE4433974C1 (de) * 1994-09-23 1996-03-28 Eberspaecher J Verfahren zur Herstellung von Katalysatoren
IT1303635B1 (it) * 1997-12-19 2001-02-21 Corning Inc Metodo di fabbricazione di un convertitore catalitico da utilizzarein un motore a combustione interna
US6381843B1 (en) * 1999-08-03 2002-05-07 Sango Co., Ltd. Method of producing a catalytic converter

Also Published As

Publication number Publication date
FR2760458A1 (fr) 1998-09-11
EP1015481A1 (de) 2000-07-05
US20030118604A1 (en) 2003-06-26
FR2760458B1 (fr) 1999-04-23
US6964852B2 (en) 2005-11-15
ATE325130T1 (de) 2006-06-15
EP1015481B1 (de) 2006-05-03
US6576240B1 (en) 2003-06-10
JP2001522352A (ja) 2001-11-13
CA2284083A1 (fr) 1998-09-11
AU6839598A (en) 1998-09-22
DE69834408T2 (de) 2007-04-19
WO1998039360A1 (fr) 1998-09-11

Similar Documents

Publication Publication Date Title
DK532184A (da) Antigene aminosyresekvenser
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
TR200102423T2 (tr) Peptid ligandları yoluyla bağlı birden fazla imünojenik bileşeni olan HBV çekirdek antijeni parçacıkları
NO893894D0 (no) Non-a, nok-b hepatittvirus antigen-peptid.
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
ATE482272T1 (de) Zytokinproteinfamilie
DE69834408D1 (de) Strukturelles peptid mit antigenischenen eigenschaften, antigenischen verbindungen und verwendungen im nachweis, vorbeugung und behandlung einer vhc-infektion
WO2002057314A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
DE69728975D1 (de) Rekombinante phagen
WO2004005316A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ATE109158T1 (de) Rubella-e1 und c peptide.
DK0551275T3 (da) Non-A non-B sekvenser
DK0426314T3 (da) HIV-relaterede peptider
EP1310512A3 (de) HCV-Kernprotein-Sequenzen
TR200202169T1 (tr) Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri.
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
WO2002051865A3 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih
ES2143918A1 (es) Peptidos inhibidores de la proteasa c y su utilizacion en la preparacion de composiciones utiles en las infecciones causadas por el virus de la hepatitis c.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition